Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma

NCT00400816 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Tumors
Brain Tumor

Interventions

DRUG: temozolomide

Sponsor

The Cleveland Clinic

Collaborators

[object Object]